BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1772 related articles for article (PubMed ID: 16282957)

  • 1. The role of endoscopic retrograde cholangiopancreatography and endoscopic ultrasound in diagnosis and treatment of acute pancreatitis.
    Kinney TP; Freeman ML
    Minerva Gastroenterol Dietol; 2005 Dec; 51(4):265-88. PubMed ID: 16282957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoscopic approach to acute pancreatitis.
    Kinney TP; Lai R; Freeman ML
    Rev Gastroenterol Disord; 2006; 6(3):119-35. PubMed ID: 16957653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRCP-secretin test-guided management of idiopathic recurrent pancreatitis: long-term outcomes.
    Testoni PA; Mariani A; Curioni S; Zanello A; Masci E
    Gastrointest Endosc; 2008 Jun; 67(7):1028-34. PubMed ID: 18179795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of unexplained acute and acute recurrent pancreatitis using endoscopic retrograde cholangiopancreatography, sphincter of Oddi manometry and endoscopic ultrasound.
    Coyle WJ; Pineau BC; Tarnasky PR; Knapple WL; Aabakken L; Hoffman BJ; Cunningham JT; Hawes RH; Cotton PB
    Endoscopy; 2002 Aug; 34(8):617-23. PubMed ID: 12173081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic pancreatic endoscopy.
    Neuhaus H
    Endoscopy; 2004 Jan; 36(1):8-16. PubMed ID: 14722850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic recurrent pancreatitis: long-term results after ERCP, endoscopic sphincterotomy, or ursodeoxycholic acid treatment.
    Testoni PA; Caporuscio S; Bagnolo F; Lella F
    Am J Gastroenterol; 2000 Jul; 95(7):1702-7. PubMed ID: 10925971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NIH state-of-the-science statement on endoscopic retrograde cholangiopancreatography (ERCP) for diagnosis and therapy.
    NIH Consens State Sci Statements; 2002 Jan 14-16; 19(1):1-26. PubMed ID: 14768653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic yield of ERCP and secretin-enhanced MRCP and EUS in patients with acute recurrent pancreatitis of unknown aetiology.
    Mariani A; Arcidiacono PG; Curioni S; Giussani A; Testoni PA
    Dig Liver Dis; 2009 Oct; 41(10):753-8. PubMed ID: 19278909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic stenting in benign pancreatic diseases.
    Testoni PA
    JOP; 2007 Jan; 8(1 Suppl):141-50. PubMed ID: 17228146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic pancreas stenting followed by needle-knife fistulotomy in patients with sphincter of Oddi dysfunction and difficult cannulation: new method to prevent post-ERCP pancreatitis.
    Madácsy L; Kurucsai G; Fejes R; Székely A; Székely I
    Dig Endosc; 2009 Jan; 21(1):8-13. PubMed ID: 19691794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventing post-ERCP pancreatitis: where are we?
    Testoni PA
    JOP; 2003 Jan; 4(1):22-32. PubMed ID: 12555013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin injection after biliary sphincterotomy.
    Gorelick A; Barnett J; Chey W; Anderson M; Elta G
    Endoscopy; 2004 Feb; 36(2):170-3. PubMed ID: 14765315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic pancreatic endoscopy.
    Neuhaus H
    Endoscopy; 2002 Jan; 34(1):54-62. PubMed ID: 11778130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphincter of Oddi dysfunction: pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone.
    Fogel EL; Eversman D; Jamidar P; Sherman S; Lehman GA
    Endoscopy; 2002 Apr; 34(4):280-5. PubMed ID: 11932782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for post-ERCP pancreatitis: a prospective multicenter study.
    Cheng CL; Sherman S; Watkins JL; Barnett J; Freeman M; Geenen J; Ryan M; Parker H; Frakes JT; Fogel EL; Silverman WB; Dua KS; Aliperti G; Yakshe P; Uzer M; Jones W; Goff J; Lazzell-Pannell L; Rashdan A; Temkit M; Lehman GA
    Am J Gastroenterol; 2006 Jan; 101(1):139-47. PubMed ID: 16405547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic stents for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Freeman ML
    Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1354-65. PubMed ID: 17981248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of complications of endoscopic retrograde cholangiopancreatography and endoscopic ultrasound in an ambulatory endoscopy center.
    Mahnke D; Chen YK; Antillon MR; Brown WR; Mattison R; Shah RJ
    Clin Gastroenterol Hepatol; 2006 Jul; 4(7):924-30. PubMed ID: 16797251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Where do ERCP, endoscopic ultrasound, magnetic resonance cholangiopancreatography, and intraoperative cholangiography fit in the management of acute biliary pancreatitis? A decision analysis model.
    Arguedas MR; Dupont AW; Wilcox CM
    Am J Gastroenterol; 2001 Oct; 96(10):2892-9. PubMed ID: 11693323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse outcomes of endoscopic retrograde cholangiopancreatography.
    Freeman ML
    Rev Gastroenterol Disord; 2002; 2(4):147-68. PubMed ID: 12481167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic pancreatic endoscopy.
    Neuhaus H
    Endoscopy; 2000 Mar; 32(3):217-25. PubMed ID: 10718387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 89.